What is the regional analysis of Medical Cannabis Market?

 

Medical Cannabis Market Highlights

Medical cannabis, also known as medical marijuana, is an herbal drug derived from plants of the genus Cannabis used to treat a specific symptom or disease. Although the word cannabis refers specifically to the plant genus, it is also used interchangeably with marijuana, which describes the crude drug isolated from the plants’ leaves and flowers.

The global Medical Cannabis Market Size is expected to cross USD 33,210.21 million by 2027 at a CAGR of 18.14% during the forecast period 2020-2027.

The key factors that drive the global medical cannabis market are the rising research & development activities and financial support by various government and private organizations for cannabinoid research. However, stringent government policies and increasing illegal use of marijuana sizes are anticipated to hamper the market growth.

Segment Analysis

The global medical cannabis market outlook has been segmented based on product type, derivative, route of administration, application, and distribution channel.

The market, based on product type, has been segregated into solid, dissolvable/powders, oil, and ointment & creams. Based on derivative, the market is bifurcated into cannabidiol and tetrahydrocannabinol. Based on route of administration, the global medical cannabis market has been segmented into inhalation, oral, and topical.

Based on application it is divided into pain management, neurological health management, and mental health management. The inhalation segment dominated the market segment is expected to register the fastest growth in the application segment of the global medical cannabis market during the forecast period. The medical cannabis market, by distribution channel, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Regional Analysis

The Americas dominated the global medical cannabis market by accounting for the largest share in 2020. This large market share is due to medical cannabis legalization in 37 US states and the increasing adoption of products. The presence of major manufacturers, the rising adoption of medical cannabis products, and an increasing number of companies involved in R&D activities are driving the growth of the market in this region. Europe holds a strong share in the global medical cannabis market. It is the second-largest market due to an increasing number of European countries legalizing cannabis for medical purposes.

Additionally, prominent research and manufacturing activities in the region are anticipated to increase the market size in this region. The increasing prevalence of diseases such as multiple sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, post-traumatic stress disorder, depression, and anxiety are fuelling the market growth in Europe. Asia-Pacific is expected to have a favourable growth rate during the forecast period, owing to the huge patient pool of cancer and government initiatives of healthcare reforms. It holds the third-largest position in the global medical cannabis market. The Middle East would depict the least growth due to major factors, such as underdeveloped regulations and lower adoption rates. The region is expected to witness a restricted growth due to stringent government policies.

Medical Cannabis Market Players

The global medical cannabis market players - Canopy Growth Corporation (Canada), Cannabis Sativa, Inc. (US), GW Pharmaceuticals plc. (UK), Emerald Health Therapeutics (Canada), Tilray, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cara Therapeutics (US), Medical Marijuana, Inc. (US), GB Sciences, Inc. (US), and Canndoc (Israel).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth Opportunities, Demand and Forecasts, 2020-2027

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device market . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Segmentation The global cardiac monitoring and  card...
Read more

Cancer Biological Therapy Market Demand, Business Strategies, Current Trends And Efficient Techniques, Forecast 2030

  Market Highlights Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. These various types of biological therapies, which are most of the times stated to biological modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies. Cancer Biological therapy market  treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such c...
Read more

Medical Imaging Software Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

  Medical Imaging Software Market Highlights Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals m...
Read more